Alphadyne Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Buy
10,300
+4,800
+87% +$4.9M 0.12% 152
2026
Q1
$5.06M Buy
5,500
+4,100
+293% +$4.16M 0.09% 290
2025
Q4
$1.5M Sell
1,400
-6,200
-82% -$5.93M 0.04% 405
2025
Q3
$5.8M Buy
7,600
+6,800
+850% +$5.06M 0.47% 42
2025
Q2
$624K Buy
+800
New +$622K 0.11% 82
2024
Q2
Sell
-26,500
Closed -$20.6M 39
2024
Q1
$20.6M Buy
26,500
+13,000
+96% +$9.25M 5.84% 6
2023
Q4
$7.87M Buy
+13,500
New +$7.88M 2.87% 8

Other funds holding LLY

Alphadyne Asset Management's LLY Position: Q2 2026 in Review

Alphadyne Asset Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 3,738 shares — an estimated $3.82M sold.

Alphadyne Asset Management first reported a position in LLY in Q2 2023 and held it in 4 quarters. The position peaked at $3.44M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alphadyne Asset Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Alphadyne Asset Management sold 3,738 Eli Lilly shares in Q2 2026, an estimated $3.82M.
  • Alphadyne Asset Management first reported a position in Eli Lilly in Q2 2023 and held it in 4 quarters.
  • Alphadyne Asset Management's Eli Lilly position peaked at $3.44M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.